Glioblastomas are characterized by presenting Isocitrate dehydrogenase (IDH) wildtype profile, usually associated with worst prognosis compared to mutant, present amplification in the epidermal growth factor receptor (EGFR), and Telomerase reverse transcriptase (TERT) promoter mutation that lead to lengthened telomeres (Louis et al., 2021). Here, TERT is linked to glioblastoma.